Dose‐dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18 F‐labelled fluorodeoxyglucose positron emission tomography‐ MRI

Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [18F]Fluorodeoxyglucose PET-MRI

(2020) Yasuko Morita et al.   DIABETES CARE

Glucose transporters in the small intestine in health and disease

(2020) Hermann Koepsell   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport

(2019) Olga Horakova et al.   Scientific Reports

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

(2019) Marc Foretz et al.   Nature Reviews Endocrinology

GDF15 mediates the effects of metformin on body weight and energy balance

(2019) Anthony P. Coll et al.   NATURE

Glucose transporter expression in the human colon

(2018) Flavia Merigo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Mechanisms of metformin action: In and out of the gut

(2018) Takahiro Minamii et al.   Journal of Diabetes Investigation

Metformin Discontinuation prior to FDG PET/CT: A Randomized Controlled Study to Compare 24- and 48-hour Bowel Activity

(2018) Ramin Hamidizadeh et al.   RADIOLOGY

A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes

(2018) Wolfgang Rathmann et al.   DIABETOLOGIA

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

(2018) Lulu Sun et al.   NATURE MEDICINE

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

(2017) Hao Wu et al.   NATURE MEDICINE

Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel

(2016) Suk Hyun Lee et al.   ANNALS OF NUCLEAR MEDICINE

Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes

(2016) Tongzhi Wu et al.   DIABETES OBESITY & METABOLISM

Metformin-related colonic glucose uptake; potential role for increasing glucose disposal?—A retrospective analysis of 18F-FDG uptake in the colon on PET–CT

(2016) Lonneke Bahler et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Metformin and the gastrointestinal tract

(2016) Laura J. McCreight et al.   DIABETOLOGIA

Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin

(2016) Kaixin Zhou et al.   NATURE GENETICS

PET/MR Versus PET/CT Imaging: Impact on the Clinical Management of Small-Bowel Crohn’s Disease

(2015) Gianluca Pellino et al.   Journal of Crohns & Colitis

Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats

(2015) Frank A Duca et al.   NATURE MEDICINE

GLUT2 Accumulation in Enterocyte Apical and Intracellular Membranes: A Study in Morbidly Obese Human Subjects and ob/ob and High Fat-Fed Mice

(2011) A. Ait-Omar et al.   DIABETES

Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function: Clinical recommendations

(2010) A. Frid et al.   DIABETES CARE